Robert Cerfolio

Professional Overview

Robert Cerfolio is an accomplished executive and medical professional serving as the Executive Vice President, Chief Operating Officer (COO) at NYU Langone Health. With extensive expertise in cardiothoracic surgery and leadership in academic medicine, he has made significant contributions to the field of lung cancer treatment and clinical excellence.

Experience Summary

Current Role

As the Executive Vice President and COO of NYU Langone Health, Cerfolio oversees the operational and strategic initiatives of this premier academic medical center. In this role, he is responsible for driving continuous improvement in patient care, research, and educational excellence. Cerfolio also serves as a Professor of Cardiothoracic Surgery and Chief of the Division of Clinical Thoracic Surgery, as well as the Director of the Lung Cancer Center.

Career Progression

Prior to his current role, Cerfolio held the position of Executive Vice President, COO, and Vice Dean at NYU Langone Health, where he led the organization's operational and administrative functions. Before joining NYU, he served as Professor and Chief of Thoracic Surgery at UAB Hospital for over 20 years, where he made significant advancements in minimally invasive surgical techniques and lung cancer treatment.

Academic Background

Cerfolio holds a Doctor of Medicine (M.D.) degree and has completed extensive post-graduate training in cardiothoracic surgery. He is a recognized expert in his field and has authored numerous peer-reviewed publications and book chapters, contributing to the advancement of medical knowledge and patient care.

Areas of Expertise

• Cardiothoracic surgery

• Minimally invasive surgical techniques

• Lung cancer treatment and management

• Academic medicine leadership

• Hospital operations and strategic planning

• Quality and patient safety initiatives

Professional Impact

Under Cerfolio's leadership, NYU Langone Health has achieved exceptional clinical outcomes and national recognition for its excellence in patient care and medical research. He has spearheaded innovative programs and initiatives that have improved access to cutting-edge treatments for lung cancer patients, while also fostering a culture of continuous learning and professional development.

Conclusion

With his extensive experience in academic medicine, surgical expertise, and strategic leadership, Robert Cerfolio continues to drive excellence and innovation in the healthcare industry. His commitment to improving patient outcomes and advancing the field of cardiothoracic surgery makes him a valuable asset to NYU Langone Health and the broader medical community.